- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04229056
Computerunterstütztes Selbsttraining zur Verbesserung der Exekutivfunktion (COMPEX)
Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Copenhagen, Dänemark
- Rigshospitalet
-
Copenhagen, Dänemark
- Bispebjerg Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- A diagnose of stroke, cardiac arrest or Parkinson's disease.
- Aged 18 years or older.
- Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
- Computer and internet access at home.
- Providing informed consent.
Inclusion criteria specific for stroke
- Inclusion within 6 months post-stroke
- Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
- Initial stroke severity >/= NIHSS 3.
Inclusion criteria specific for cardiac arrest
• Inclusion within 6 months post ictus.
Inclusion criteria specific for Parkinson's disease
- Clinical diagnosis of PD.
- Anti-parkinsonian medical treatment (dopaminergic or other).
Exclusion Criteria:
- Informed consent not provided
- Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
- Not able to participate according to investigator
Exclusion criteria specific for stroke
- Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
- Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.
Exclusion criteria specific for cardiac arrest • None
Exclusion criteria specific for PD
• Diagnosis of PD Dementia according to the MDS PD Dementia criteria
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Specific computer-based cognitive rehabilitation
154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions. |
CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions. |
|
Aktiver Komparator: General computer-based cognitive stimulation
154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities. |
For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
CABPad Working Memory Test
Zeitfenster: After the end of the intervention (8 weeks after baseline)
|
Test of working memory. The higher score the better (theoretically infinite score) |
After the end of the intervention (8 weeks after baseline)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
CABPad Working Memory Test - 3 months follow-up
Zeitfenster: At follow-up visit 3 months after end of intervention
|
Test of working memory. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after end of intervention
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making A
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making A
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making B
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making B
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
SDMT
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
SDMT
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Phonological verbal fluency test
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Phonological verbal fluency test
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Categorical verbal fluency test
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Categorical verbal fluency test
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Fear questionnaire
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
Directly after the intervention, eight weeks after inclusion
|
|
Fear questionnaire
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
At follow-up visit 3 months after the end of the intervention
|
|
mrs: Modified Rankin Scale
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
mrs: Modified Rankin Scale
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
EuroQol-5 domain (EQ-5D-5L)
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner |
Directly after the intervention, eight weeks after inclusion
|
|
EuroQol-5 domain (EQ-5D-5L)
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner |
At follow-up visit 3 months after the end of the intervention
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
Compliance
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Monitoring of total time spent training in minutes |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Zeitfenster: At follow-up visit 3 months after the end of the intervention
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
2) visual analogue scale (1-10)
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more. |
Directly after the intervention, eight weeks after inclusion
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Zeitfenster: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
Directly after the intervention, eight weeks after inclusion
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Hanne Christensen, Professor, Bispebjerg Hospital
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Synucleinopathien
- Zerebrovaskuläre Erkrankungen
- Erkrankungen des Gehirns
- Erkrankungen des zentralen Nervensystems
- Erkrankungen des Nervensystems
- Gefäßerkrankungen
- Herz-Kreislauf-Erkrankungen
- Psychische Störungen
- Herzkrankheiten
- Neurokognitive Störungen
- Kognitionsstörungen
- Neurodegenerative Krankheiten
- Bewegungsstörungen
- Parkinsonsche Störungen
- Erkrankungen der Basalganglien
- Streicheln
- Kognitive Dysfunktion
- Herzstillstand
- Parkinson Krankheit
Andere Studien-ID-Nummern
- H-19039236
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
This is currently undecided
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .